AstaTech
Leading Pharmaceutical CRO/CMO with Economic Manufacturing Capabilities

In the wake of the pandemic, supply chain issues and shipping delays have bogged down almost every industry, and the chemical industry was no exception. Even today’s post pandemic world is facing the aftermath of the disruptions, causing shipping contract violations and costing the industry millions of dollars. This is where AstaTech, backed by over 26 years of chemistry expertise, makes a world of difference with its commitment and competency to ship products within just 24 hours. As one of the earliest leading pharmaceutical CRO/CMO in the US, run by former senior scientists from the pharmaceutical industry, AstaTech specializes in offering advanced intermediates, custom synthesis, FTE production, catalog products, and analytical services.

The company offers a catalog of over 250,000 advanced drug like ‘building blocks,’ of which 80 percent are always available in stock for delivery. All of the company’s listed in stock compounds can be shipped overnight and delivered in a day or two domestically, and within a week in most countries anywhere in the world. Dr. Shan Jiang, BD Manager of AstaTech, says, “10 percent of our products can be easily scaled up to kg/MT scales, and we’re adding 20-30 thousand stock products to our portfolio each year. “ Be it for shipping new products in varying quantities or commonly used products in bulk, AstaTech, while fully leveraging its economic manufacturing capabilities, also emphasizes organic sensitivity and the analytical test of all chemicals for quality control.

“Be it for any volume of product, I follow-up with the entire manufacturing and delivery process to ensure that every requirement of the project is met effectively,” adds Jiang.

AstaTech also caters to academic institutions like Scripps Research, Harvard university, and Oxford University.

Evidently, the company’s services are driven by its core value to innovate and provide products for the latest studies in drug discovery and clients’ requirements. With such a value proposition, AstaTech positioned itself among the leading research and development support providers for fighting the pandemic. Jiang states, “AstaTech’s success with more than 1000 organizations like Pfizer during COVID-19 is a testament to its subject matter proficient employees in every department.”

AstaTech’s expert workforce is another of its key differentiators. While the company’s sales team operates at the forefront of customer interaction handling all queries, price quotations, and delivery of crucial information, its business development team strategizes—on clients’ behalf—to develop products cost-effectively. The company also employs PhD-level employees within their technical teams in the US who ensure all products in-sourced from the China-based manufacturing hub and pilot plants are free from any chemical-related issues. Moreover, they work closely with the quality assurance teams to conduct an in-depth quality check and provide the certificate of analysis (COA) for conforming to all customer requirements.

AstaTech’s holistic approach to serving clients has enabled them to script several customer success stories. In one such instance, the firm helped a pharmaceutical company developing a novel drug which now is in Phase II studies. AstaTech’s teams communicated with the client over a couple of weeks and developed the crystalline chemical with 99% purity, helping the client kickstart the development process.

In a nutshell, be it for drug discovery or manufacturing, AstaTech’s dedicated workforce comprising chemists, quality control specialists, manufacturing experts, and sales executives can deliver products more time-efficiently than the common market standards. Additionally, the firm is equipped with the infrastructure to scale up the manufacturing and delivery of any product from grams to multi-kilo to ton scales.